Esperion Therapeutics Inc. (ESPR)
NASDAQ · Healthcare
Esperion Therapeutics Inc. Income Statement 2018–2025
| Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 | Dec 2019 | Dec 2018 | |
|---|---|---|---|---|---|---|---|---|
| Revenues | ||||||||
| Revenue | 403.1M | 332.3M | 116.3M | 75.5M | 78.4M | 227.5M | 148.4M | 0 |
| Gross Profit | — | — | — | — | — | — | — | — |
| Profitability | ||||||||
| Operating Income | 60.3M | 54.4M | -155.6M | -179.5M | -226.7M | -121.4M | -93.1M | -204.6M |
| EBITDA | — | — | — | — | — | — | — | — |
| Net Income | -22.7M | -51.7M | -209.2M | -233.7M | -269.1M | -143.6M | -97.2M | -201.8M |
| Per Share Data | ||||||||
| EPS (diluted) | $-0.11 | $-0.28 | $-2.03 | $-3.52 | $-9.31 | $-5.23 | $-3.59 | — |
| Shares Outstanding (dil.) | 208M | 187M | 103M | 66M | 29M | 27M | 27M | 27M |
Esperion Therapeutics Inc. Income Statement — FAQ
Esperion Therapeutics Inc. (ESPR) income statement over the last 8 years — annual and quarterly figures with year-over-year growth and charts.
Where can I see ESPR's income statement history?
The chart and table above show Esperion Therapeutics Inc.'s income statement by year and by quarter, including the growth rate.